Market Value2,621,402,000
Total Holdings79
File Date2022-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BLSA / BCLS Acquisition Corp - Class A
SOPH / SOPHiA GENETICS SA
SANA / Sana Biotechnology, Inc.
PRAX / Praxis Precision Medicines, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
EW / Edwards Lifesciences Corporation
RCUS / Arcus Biosciences, Inc.
QURE / uniQure N.V.
UNH / UnitedHealth Group Incorporated
BDX / Becton, Dickinson and Company
CTLT / Catalent, Inc.
MYGN / Myriad Genetics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
MRK / Merck & Co., Inc.
DXCM / DexCom, Inc.
LLY / Eli Lilly and Company
IQV / IQVIA Holdings Inc.
ICLR / ICON Public Limited Company
PRCT / PROCEPT BioRobotics Corporation
THC / Tenet Healthcare Corporation
OSH / Oak Street Health Inc
CANO / Cano Health, Inc.
BIIB / Biogen Inc. Call
PFE / Pfizer Inc.
AERI / Aerie Pharmaceuticals Inc
BAX / Baxter International Inc.
FLDM / Standard BioTools Inc
PARDES BIOSCIENCES INC / (69945Q105)
GILD / Gilead Sciences, Inc.
SEAGEN INC / CALL Call (81181C904)
CCCC / C4 Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
SRRA / Sierra Oncology Inc
ITOS / iTeos Therapeutics, Inc.
OM / Outset Medical, Inc.
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
SGHT / Sight Sciences, Inc.
JYAC / Jiya Acquisition Corp - Class A
EDIT / Editas Medicine, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
JAZZ / Jazz Pharmaceuticals plc
BCRX / BioCryst Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc. Call
US268158AD40 / Dynavax Technologies Corp
US00771VAB45 / Aerie Pharmaceuticals Inc
GILD / Gilead Sciences, Inc. Call
WAT / Waters Corporation
PEN / Penumbra, Inc.
PRTA / Prothena Corporation plc
ERAS / Erasca, Inc.
CNC / Centene Corporation
JNCE / Jounce Therapeutics Inc
ICUI / ICU Medical, Inc.
DVAX / Dynavax Technologies Corporation
ISEE / IVERIC bio Inc
NVRO / Nevro Corp.
HZNP / Horizon Therapeutics Plc
CYTK / Cytokinetics, Incorporated
NTLA / Intellia Therapeutics, Inc.
VEEV / Veeva Systems Inc.
BMRN / BioMarin Pharmaceutical Inc.
MOH / Molina Healthcare, Inc.
CI / The Cigna Group
KRTX / Karuna Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc. Call
HCA / HCA Healthcare, Inc.
GBIO / Generation Bio Co.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
TMO / Thermo Fisher Scientific Inc.
CAH / Cardinal Health, Inc.
VERV / Verve Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
PMVP / PMV Pharmaceuticals, Inc.
JNJ / Johnson & Johnson
ABBV / AbbVie Inc.
EPIX / ESSA Pharma Inc.
HUM / Humana Inc.
ELV / Elevance Health, Inc.
MCK / McKesson Corporation
UHS / Universal Health Services, Inc.
IRTC / iRhythm Holdings, Inc.
SGEN / Seagen Inc
DHR / Danaher Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
AXSM / Axsome Therapeutics, Inc.
HOWL / Werewolf Therapeutics, Inc.
IOBT / IO Biotech, Inc.
AVTR / Avantor, Inc.
CRBU / Caribou Biosciences, Inc.